Coronavirus Massive Simulations Completed on Supercomputer
New simulations can help researchers design new drugs and vaccines to combat the coronavirus
Drug Development
Inactivated Human Receptor Will Help to Create Effective Drugs
The membrane receptors that ensure that human cells function properly count among the most sought after drug targets
Scientists Identify Potential Targets for Immune Responses to SARS-CoV-2
Their analysis provides essential information for vaccine design and the evaluation of diagnostics and vaccine candidates
New Coronavirus Protein Reveals Drug Target
A potential drug target has been identified in a newly mapped protein of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19
zPREDICTA Enters Strategic Collaboration with LabCorp to Advance the Use of 3D Cell Cultures in Research and Drug Development
The collaboration combines zPREDICTA’s strengths in the development of clinically relevant 3D cell culture models with LabCorp’s strengths in drug development and precision medicine
Certara Announces the Availability of PK Submit, its Pharmacokinetic CDISC Technology Solution
PK Submit generates PK CDISC domains automatically, allowing sponsors to file regulatory submissions faster, while also improving data organization and compliance
Abzena Showcases Discovery and Developability Services at PEGS Europe 2019
Bespoke approach generates high affinity antibodies and selects lead candidates with the strongest chances of success in the clinic
BIA Separations Introduces Cornerstone Exosome Process Development Solution to Enable Industrial Scale Manufacture of Therapeutic Exosomes
Platform combines proprietary new technologies for high yield purification of exosomes: Kryptonase™ and CIMmultus™ EV monolithic column